Angela Ianniciello

Angela Ianniciello

Auto-generated profile, based on publicly available information

Angela Ianniciello

Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
AIAngela Ianniciello
Angela Ianniciello
MZMartha M. Zarou
Martha M. Zarou
KRKevin M. Rattigan
Kevin M. Rattigan
MSMary Scott
Mary Scott
ADAmy Dawson
Amy Dawson
VHVignir Helgason
Vignir Helgason
ULK1 inhibition increases the sensitivity of leukemia stem cells to TKI therapy by modulating energy and redox balance.

30 June 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
AIAngela Ianniciello
Angela Ianniciello
PDPierre-Yves Dumas
Pierre-Yves Dumas
CDClaire Drullion
Claire Drullion
AGAmélie Guitart
Amélie Guitart
AVArnaud VILLACRECES
Arnaud VILLACRECES
Jean-max PasquetJean-max Pasquet
Jean-max Pasquet
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence

25 July 2023 in EMBO Reports
Verified
Journal Article
Open access
KRKevin M Rattigan
Kevin M Rattigan
MZMartha M Zarou
Martha M Zarou
ZBZuzana Brabcova
Zuzana Brabcova
BPBodhayan Prasad
Bodhayan Prasad
DZDésirée Zerbst
Désirée Zerbst
VHVignir Helgason
Vignir Helgason
To fuel accelerated proliferation, leukaemic cells undergo metabolic deregulation, which can result in specific nutrient dependencies. Here, we perform an amino acid drop‐out screen and apply pre‐clinical models of chronic phase chronic myeloid leukaemia (CML) to identify arginine as a nutrient essential for primary human CML cells. Analysis of the Microarray Innovations in Leukaemia (MILE) dataset uncovers reduced ASS1 levels in CML compared to most other leukaemia types. Stable isotope tracing reveals repressed activity of all urea cycle enzymes in patient‐derived CML CD34 + cells, rendering them arginine auxotrophic. Thus, arginine deprivation completely blocks proliferation of CML CD34 + cells and induces significantly higher levels of apoptosis when compared to arginine‐deprived cell lines. Similarly, primary CML cells, but not normal CD34 + samples, are particularly sensitive to treatment with the arginine‐depleting enzyme, BCT‐100, which induces apoptosis and reduces clonogenicity. Moreover, BCT‐100 is highly efficacious in a patient‐derived xenograft model, causing > 90% reduction in the number of human leukaemic stem cells (LSCs). These findings indicate arginine depletion to be a promising and novel strategy to eradicate therapy resistant LSCs.